---
title: "Ibrutinib - Waldenström macroglobulinemia"
sidebar: mydoc_sidebar
permalink: db09053-mesh-d008258-1.html
toc: false 
---


Path ID: `DB09053_MESH_D008258_1`
{% include image.html url="images/db09053-mesh-d008258-1.png" file="db09053-mesh-d008258-1.png" alt="db09053-mesh-d008258-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C551803 | ibrutinib | Drug |
| UniProt:Q06187 | Tyrosine-protein kinase BTK | Protein |
| GO:0050853 | B cell receptor signaling pathway | BiologicalProcess |
| GO:0002368 | B cell cytokine production | BiologicalProcess |
| GO:0060326 | cell chemotaxis | BiologicalProcess |
| GO:0006915 | apoptotic process | BiologicalProcess |
| MESH:D008258 | Waldenström macroglobulinemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ibrutinib | NEGATIVELY REGULATES | Tyrosine-Protein Kinase Btk |
| Tyrosine-Protein Kinase Btk | POSITIVELY REGULATES | B Cell Receptor Signaling Pathway |
| B Cell Receptor Signaling Pathway | POSITIVELY REGULATES | B Cell Cytokine Production |
| B Cell Receptor Signaling Pathway | NEGATIVELY CORRELATED WITH | Apoptotic Process |
| B Cell Receptor Signaling Pathway | POSITIVELY CORRELATED WITH | Cell Chemotaxis |
| Cell Chemotaxis | POSITIVELY CORRELATED WITH | Waldenström Macroglobulinemia |
| B Cell Cytokine Production | POSITIVELY CORRELATED WITH | Waldenström Macroglobulinemia |
| Apoptotic Process | NEGATIVELY CORRELATED WITH | Waldenström Macroglobulinemia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB09053#mechanism-of-action](https://go.drugbank.com/drugs/DB09053#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Ibrutinib#Mechanism](https://en.wikipedia.org/wiki/Ibrutinib#Mechanism)
  - [https://en.wikipedia.org/wiki/Ibrutinib#Medical_uses](https://en.wikipedia.org/wiki/Ibrutinib#Medical_uses)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632638/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632638/)

Reference: 
  - [https://go.drugbank.com/drugs/DB09053#mechanism-of-action](https://go.drugbank.com/drugs/DB09053#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Ibrutinib#Mechanism](https://en.wikipedia.org/wiki/Ibrutinib#Mechanism)
  - [https://en.wikipedia.org/wiki/Ibrutinib#Medical_uses](https://en.wikipedia.org/wiki/Ibrutinib#Medical_uses)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632638/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632638/)

Reference: 
  - [https://go.drugbank.com/drugs/DB09053#mechanism-of-action](https://go.drugbank.com/drugs/DB09053#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Ibrutinib#Mechanism](https://en.wikipedia.org/wiki/Ibrutinib#Mechanism)
  - [https://en.wikipedia.org/wiki/Ibrutinib#Medical_uses](https://en.wikipedia.org/wiki/Ibrutinib#Medical_uses)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632638/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632638/)

Reference: 
  - [https://go.drugbank.com/drugs/DB09053#mechanism-of-action](https://go.drugbank.com/drugs/DB09053#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Ibrutinib#Mechanism](https://en.wikipedia.org/wiki/Ibrutinib#Mechanism)
  - [https://en.wikipedia.org/wiki/Ibrutinib#Medical_uses](https://en.wikipedia.org/wiki/Ibrutinib#Medical_uses)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632638/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632638/)
